News

Researchers believe the flavonoids in oranges offer protection against late stage macular degeneration.

Researchers published the results of a recent study in Science Reports. The study revealed that the severity and progression of AMD could be determined by measuring the level of VEGF in the tears o...

For patients suffering from age-related macular degeneration, gene therapy has the potential to transfigure the treatment options that are available.

The latest hurdle that was jumped for the implantable device was the successful implantation in sheep.

Researchers at the University of Toronto have developed a new technique of injecting healthy cells into eyes affected by vision loss due to age-related macular degeneration (AMD) or retinitis pigme...

Currently, there are no FDA-approved treatments available to treat dry AMD. Lineage Cell Therapeutics is currently conducting a clinical trial on its newest cell transplant product developed to tre...

Researchers from the Queen Mary University of London have found that age-related macular degeneration is potentially caused by the failure of at least one of five proteins to regulate the immune s...

A research team at the University of Utah found that low levels of a protein known as HTRA1 could be a trigger for the development of age-related macular degeneration (AMD) in specific individuals.

The new device offers a continuous therapeutic dose of ranibizumab to the eye in place of regular eye injections.